-Helix mimicry with /-peptides
The quality of available evidence is further limited by methodological concerns, including small sample sizes, short study durations, lack of standardisation in probiotic formulations, and potential publication bias favouring positive results
This includes baseline labs, follow-up testing, vital sign monitoring, and dose adjustments based on the patients individual response
FDA approval in the US is expected in 2026 to 2027, with Health Canada approval likely following
Full detailed safety data will be presented at the American Diabetes Association 86th Scientific Sessions
Berjis rule of thumb makes the distinction even easier to understand: Maintenance is like wearing comfy sneakers every day, while microdosing is like only wearing them when you know youll be walking a lot. It all comes down to timing and individual needs.